Latest News

Meiogen is awarded US Patents #7,285,526 and #7,887,814 B2
These patents cover the composition of the lead compound Normferon™, its modifications and its use in the treatment of a diverse range of immunological and neurological diseases.




Normferon™ is expected to be the first,
safest, and most effective interferon
inhibitor available.


read more


  • Autoimmune Disease
  • HIV/AIDS
  • Down Syndrome
  • Transplant Rejection

read more




Making interferon levels normal again

There are currently no FDA-approved interferon inhibitors available.  Meiogen could be the first.

read more